Trial Profile
Phase II Trial of Endostar Combined With CHOPT for T Cell Lymphoma.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2015
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cyclophosphamide; Pirarubicin; Prednisone; Teniposide; Vincristine
- Indications T-cell lymphoma
- Focus Therapeutic Use
- 03 Nov 2015 Planned End Date changed from 1 Jun 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.
- 03 Nov 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Nov 2015, according to ClinicalTrials.gov record.
- 21 Apr 2014 Planned End Date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.